Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia. Walter W, et al. BMC Cancer. 2021 Aug 2;21(1):886.
Comment on: Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers (Duncavage et al. N Engl J Med 2021;384:924-935). Haferlach T et al. N Engl J Med. 2021 Jun 24;384(25):e106.
Analytical Demands to Use Whole-Genome Sequencing in Precision Oncology. Meggendorfer M et al. Semin Cancer Biol. 2021 Jun 10;S1044-579X(21)00179-6. Online ahead of print.
Clinical utility of whole-genome sequencing in precision oncology. Rosenquist R et al. Semin Cancer Biol. 2021 Jun 24;S1044-579X(21)00189-9. Online ahead of print.
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes. Bersanelli M et al. J Clin Oncol. 2021 Apr 10;39(11):1223-1233.
Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS. Stengel et al. Blood Adv. 2020 Nov 10;4(21):5393-5401.
Next-generation diagnostics for precision oncology: Preanalytical considerations, technical challenges, and available technologies. Walter et al. Semin Cancer Biol. 2020 Nov 7;S1044-579X(20)30220-0. Online ahead of print.
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms. Palomo L et al. Blood. 2020 Oct 15;136(16):1851-1862.
The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time? Höllein A et al. Cancer Genet. 2020 Apr;242:15-24.
Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation. Mas-Peiro S et al. Eur Heart J. 2020 Feb 21;41(8):933-939.
A Novel Machine Learning Based in silico Pathogenicity Predictor for Missense Variants in a Hematological Setting. Hutter et al. Blood (2019) 134 (Supplement_1): 2090.